Evaluation of the Benefits and Risks of Low-Dose Aspirin in the Secondary Prevention of Cardiovascular and Cerebrovascular Events | Zendy

Steven M. Weisman | Zendy; David Y. Graham | Zendy

Open Access

Evaluation of the Benefits and Risks of Low-Dose Aspirin in the Secondary Prevention of Cardiovascular and Cerebrovascular Events

Author(s) -

Steven M. Weisman,

David Y. Graham

Publication year - 2002

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.162.19.2197

Subject(s) - aspirin , medicine , gastrointestinal bleeding , secondary prevention , placebo , low dose aspirin , gastrointestinal tract , primary prevention , intensive care medicine , disease , pathology , alternative medicine

In spite of the clear evidence of benefit of aspirin in the secondary prevention of cerebrovascular and cardiovascular thrombotic events, its use in patients at high risk due to a previous event remains suboptimal. A possible explanation for this underuse is concern regarding the relative benefit in relation to the potential risk for serious gastrointestinal events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research